ACCENDRA HEALTH INC/VA/
ACHNYSE
$3.47
↓ -8.2%Jul 17 close · end-of-day
Price
1Y↓ -56.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$265.2M
Enterprise Value
$2.0B
P/E
—
P/S
0.1
P/B
—
EV/EBITDA
7.9
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$2.7B
Net Income (TTM)
-$1.1B
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
0.9%
Net Margin
-39.8%
ROE
232.8%
ROIC
1.5%
Debt / Equity
-4.5
Net Cash
-$1.8B
Return 1Y
-56.6%
Company profile
Owens & Minor, Inc. operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels.
- CEO
- Edward A. Pesicka
- Sector
- Wholesale Trade
- Industry
- Wholesale
- Employees
- 22,500
- Headquarters
- Virginia
- Website
- owens-minor.com
Management & directors
- Galloway Heath HEVP,General Counsel & CorpSecy
- Bernocchi Perry AEVP, Chief Operating Officer
- Leon Jonathan AEVP & CFO
- Pesicka Edward APresident & CEO
- Long Andrew GEVP, CEO P&HS
Roles derived from SEC Form 4 filings.
Earnings
ACH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$627.8M↓ -6.8%
Diluted EPS-$0.08↓ -75.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $8.5B | $9.8B | $10.0B | $2.6B | $2.7B | $2.8B |
| Gross profit | $1.3B | $1.5B | $1.8B | $2.1B | $2.2B | — |
| Operating income | $204.1M | $368.5M | $142.9M | $133.2M | -$217.7M | $27.5M |
| Net income | $29.9M | $221.6M | $22.4M | -$41.3M | -$362.7M | -$1.1B |
| Diluted EPS | $0.47 | $2.94 | $0.29 | -$0.53 | -$4.73 | -$14.31 |
| Operating cash flow | $339.2M | $124.2M | $325.0M | $740.7M | $161.5M | — |
| Free cash flow | $288.8M | $83.2M | $166.9M | $568.3M | -$8.8M | — |
| Gross margin | 15.1% | 15.5% | 18.3% | 83.3% | 82.8% | — |
| Operating margin | 2.4% | 3.8% | 1.4% | 5.2% | -8.1% | 1.0% |
| Net margin | 0.4% | 2.3% | 0.2% | -1.6% | -13.5% | -39.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $660.4M | $686.8M | -$1.3B | $673.9M | $681.9M | $697.3M | $709.0M | $627.8M |
| Gross profit | $544.2M | $559.7M | $579.8M | $526.0M | — | — | — | — |
| Operating income | $16.9M | $31.1M | -$275.4M | $19.8M | -$39.7M | $26.5M | $20.9M | $17.1M |
| Net income | -$31.9M | -$12.8M | -$296.1M | -$25.0M | -$869.1M | -$150.3M | -$56.3M | -$6.5M |
| Diluted EPS | -$0.42 | -$0.16 | -$3.86 | -$0.32 | -$11.30 | -$1.94 | -$0.75 | -$0.08 |
| Operating cash flow | $116.1M | $27.3M | $71.0M | -$35.1M | $37.6M | -$172.5M | — | — |
| Free cash flow | $71.8M | -$30.3M | $48.7M | -$80.9M | -$40.2M | -$226.8M | — | — |
| Gross margin | 82.4% | 81.5% | -45.3% | 78.1% | — | — | — | — |
| Operating margin | 2.6% | 4.5% | 21.5% | 2.9% | -5.8% | 3.8% | 2.9% | 2.7% |
| Net margin | -4.8% | -1.9% | 23.1% | -3.7% | -127.4% | -21.6% | -7.9% | -1.0% |
Company news
Jul 2, 2026
Jun 24, 2026
Jun 10, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-18 | Galloway Heath H· EVP,General Counsel & CorpSecy | Tax withholding | 1,822 | $2.91 | $5,302.02 | filing |
| 2026-05-15 | Pesicka Edward A· President & CEO | Tax withholding | 17,692 | $3.04 | $53,783.68 | filing |
| 2026-05-15 | Bernocchi Perry A· EVP, Chief Operating Officer | Tax withholding | 7,908 | $3.04 | $24,040.32 | filing |
| 2026-05-15 | Leon Jonathan A· EVP & CFO | Tax withholding | 1,770 | $3.04 | $5,380.80 | filing |
| 2026-05-15 | Galloway Heath H· EVP,General Counsel & CorpSecy | Tax withholding | 966 | $3.04 | $2,936.64 | filing |
| 2026-05-14 | Kline Teresa L. | Award | 31,191 | $0.00 | $0.00 | filing |
| 2026-05-14 | Klemash Stephen W | Award | 31,191 | $0.00 | $0.00 | filing |
| 2026-05-14 | Gardner-Smith Kenneth | Award | 31,191 | $0.00 | $0.00 | filing |
| 2026-05-14 | Beck Mark A | Award | 31,191 | $0.00 | $0.00 | filing |
| 2026-03-20 | Pesicka Edward A· President & CEO | Tax withholding | 58,945 | $2.03 | $119,658.35 | filing |
| 2026-03-20 | Bernocchi Perry A· EVP, Chief Operating Officer | Tax withholding | 20,841 | $2.03 | $42,307.23 | filing |
| 2026-03-20 | Leon Jonathan A· EVP & CFO | Tax withholding | 11,286 | $2.03 | $22,910.58 | filing |
| 2026-03-20 | Galloway Heath H· EVP,General Counsel & CorpSecy | Tax withholding | 9,347 | $2.03 | $18,974.41 | filing |
| 2026-03-09 | Bernocchi Perry A· EVP, Chief Operating Officer | Award | 108,696 | $0.00 | $0.00 | filing |
| 2025-11-19 | Long Andrew G· EVP, CEO P&HS | Gift | 47,908 | $0.00 | $0.00 | filing |
| 2025-09-23 | Leon Jonathan A· EVP & CFO | Tax withholding | 4,265 | $5.40 | $23,031.00 | filing |
| 2025-08-14 | Coliseum Capital Management, LLC | Buy | 492,852 | $5.31 | $2.6M | filing |
| 2025-08-13 | Coliseum Capital Management, LLC | Buy | 325,000 | $5.46 | $1.8M | filing |
| 2025-08-12 | Coliseum Capital Management, LLC | Buy | 720,000 | $5.15 | $3.7M | filing |
Latest 19 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.